Detoxification Pathways in the Liver
The liver plays an important rôle in protecting the organism from potentially toxic chemical insults through its capacity to convert lipophiles into more water-soluble metabolites which can be efficiently eliminated from the body via the urine. This protective ability of the liver stems from the expression of a wide variety of xenobiotic biotransforming enzymes whose common underlying feature is their ability to catalyse the oxidation, reduction and hydrolysis (Phase I) and/or conjugation (Phase II) of functional groups on drug and chemical molecules. The broad substrate specificity, isoenzyme multiplicity and inducibility of many of these enzyme systems make them particularly well adapted to handling the vast array of different chemical structures in the environment to which we are exposed daily. However, some chemicals may also be converted to more toxic metabolites by certain of these enzymes, implying that variations in the latter may be important predisposing factors for toxicity. Pharmacogenetic defects of xenobiotic biotransformation enzymes, a subclass of inborn errors of metabolism which are manifested only upon drug challenge, introduce marked variation into human populations for the pharmacokinetics and pharmacodynamics of therapeutic and toxic agents, and thus may have important clinical consequences for drug efficacy and toxicity.
KeywordsAcetylator Phenotype Detoxification Pathway Drug Biotransformation Slow Acetylator Phenotype Potential Clinical Consequence
Unable to display preview. Download preview PDF.
- Blum, M., Demierre, A., Grant, D. M., Heim, M. and Meyer, U. A. Molecular mechanism of slow acetylation of drugs and carcinogens in man. Proc. Natl. Acad. Sci. USA (1991) (in press)Google Scholar
- Gonzalez, F. J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40 (1989) 243–288Google Scholar
- Jakoby, W. B. Detoxication: conjugation and hydrolysis. In Arias, I. M., Jakoby, W. B., Popper, H., Schacter, D. and Shafritz, D. A. (eds.), The Liver: Biology and Pathobiology, Raven Press, New York, 1988, pp. 375–388Google Scholar
- Meyer, U. A., Zanger, U. M., Grant, D. M. and Blum, M. Genetic polymorphisms of drug metabolism. Adv. Drug Res. 19 (1990) 197–241Google Scholar
- Ziegler, D. M. Detoxication: oxidation and reduction. In Arias, I. M., Jakoby, W. B., Popper, H., Schacter, D. and Shafritz, D. A. (eds.), The Liver: Biology and Pathobiology, Raven Press, New York, 1988, pp. 363–374Google Scholar